Sintx Technologies (SINT) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 69.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.05% |
| Dec 31, 2025 | 47.84% |
| Sep 30, 2025 | 48.97% |
| Jun 30, 2025 | 95.00% |
| Mar 31, 2025 | 35.06% |
| Dec 31, 2024 | 26.38% |
| Sep 30, 2024 | 77.11% |
| Mar 31, 2024 | -34.37% |
| Dec 31, 2023 | -29.39% |
| Sep 30, 2023 | -30.17% |
| Jun 30, 2023 | -30.22% |
| Mar 31, 2023 | -37.44% |
| Dec 31, 2022 | -39.59% |
| Sep 30, 2022 | -55.48% |
| Jun 30, 2022 | -30.96% |
| Mar 31, 2022 | -36.67% |
| Dec 31, 2021 | -81.86% |
| Sep 30, 2021 | -161.80% |
| Mar 31, 2021 | 116.30% |
| Dec 31, 2020 | 54.60% |
| Sep 30, 2020 | 48.12% |
| Jun 30, 2020 | 61.09% |
| Mar 31, 2020 | 49.72% |
| Dec 31, 2019 | 56.98% |
| Sep 30, 2019 | 83.14% |
| Jun 30, 2019 | 72.61% |
| Mar 31, 2019 | 54.83% |
| Dec 31, 2018 | 39.57% |
| Sep 30, 2018 | -31.73% |
| Mar 31, 2018 | 43.28% |
| Dec 31, 2017 | -18.56% |
| Sep 30, 2017 | 14.22% |
| Jun 30, 2017 | 16.20% |
| Mar 31, 2017 | 20.90% |
| Dec 31, 2016 | 35.48% |
| Sep 30, 2016 | -28.43% |
| Jun 30, 2016 | -32.35% |
| Mar 31, 2016 | -46.20% |